“Advancing TRIOLEX into a Phase I/II human clinical spectacular exploit be a of the essential oil exploit all for our fortification program target metabolic disorder,” stated Richard B. Hollis, Chairman and Chief Executive Officer of Hollis-Eden. “Type 2 diabetes is the epidemic of the 21st Century, and given the sideways effects associated to [...]
Entries from November 2008
Hollis-Eden Pharmaceuticals Commencing Phase I/II Clinical Trial With TRIOLEX (HE3286) In Obese, Insulin Resistant Volunteers Part 2
November 2nd, 2008 · 1 Comment
Tags: Uncategorized
